The discovery and development of ketamine and now esketamine as rapidly acting antidepressants has been one of the major advances in the treatment of mood disorders in the past five decades.

This Webinar will provide a brief history of the discovery and development process and will provide an overview of the various clinical trials completed to date.

Discussion will focus on addressing clinically relevant questions related to the use of this exciting new treatment approach and the potential benefits this drug can offer to those with treatment-resistant depression.

Tuesday, May 14, 2019, 2:00 pm EDT